Silk fibroin nanoparticle as a novel drug delivery system.

Design and synthesis of efficient drug delivery systems are of vital importance for medicine and healthcare. Nanocarrier-based drug delivery systems, in particular nanoparticles, have generated great excitement in the field of drug delivery since they provide new opportunities to overcome the limitations of conventional delivery methods with regards to the drugs. Silk fibroin (SF) is a naturally occurring protein polymer with several unique properties that make it a suitable material for incorporation into a variety of drug delivery vehicles capable of delivering a range of therapeutic agents. SF matrices have been shown to successfully deliver anticancer drugs, small molecules, and biomolecules. This review will provide an in-depth discussion of the development of SF nanoparticle-based drug delivery systems.

[1]  David L. Kaplan,et al.  BMP-silk composite matrices heal critically sized femoral defects. , 2007, Bone.

[2]  V. Labhasetwar,et al.  Targeted Drug Delivery in Cancer Therapy , 2005, Technology in cancer research & treatment.

[3]  P. Sabbatini,et al.  Phase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  David L Kaplan,et al.  Mechanisms of monoclonal antibody stabilization and release from silk biomaterials. , 2013, Biomaterials.

[5]  S. Nie,et al.  Therapeutic Nanoparticles for Drug Delivery in Cancer Types of Nanoparticles Used as Drug Delivery Systems , 2022 .

[6]  Juliane Nguyen,et al.  Biodegradable polymeric nanocarriers for pulmonary drug delivery , 2008 .

[7]  Fang Xie,et al.  Effect of shearing on formation of silk fibers from regenerated Bombyx mori silk fibroin aqueous solution. , 2006, International journal of biological macromolecules.

[8]  R. Zhuo,et al.  Poly(N‐isopropylacrylamide) Nanoparticle‐Incorporated PNIPAAm Hydrogels with Fast Shrinking Kinetics , 2005 .

[9]  Xuebin B. Yang,et al.  Silk scaffolds for dental tissue engineering , 2014 .

[10]  David L Kaplan,et al.  The use of sulfonated silk fibroin derivatives to control binding, delivery and potency of FGF-2 in tissue regeneration. , 2010, Biomaterials.

[11]  Vladimir Volloch,et al.  Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. , 2004, Journal of biomedical materials research. Part A.

[12]  Samir Mitragotri,et al.  Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Z. Shao,et al.  Effect of pH and copper(II) on the conformation transitions of silk fibroin based on EPR, NMR, and Raman spectroscopy. , 2004, Biochemistry.

[14]  A. Detsi,et al.  Encapsulation of the natural antioxidant aureusidin in biodegradable PLA nanoparticles , 2014 .

[15]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[16]  Ulrich Beyer,et al.  Liposomal encapsulated anti-cancer drugs. , 2005, Anti-cancer drugs.

[17]  David L Kaplan,et al.  Silk coatings on PLGA and alginate microspheres for protein delivery. , 2007, Biomaterials.

[18]  Baorui Liu,et al.  Facile preparation of paclitaxel loaded silk fibroin nanoparticles for enhanced antitumor efficacy by locoregional drug delivery. , 2013, ACS applied materials & interfaces.

[19]  Fumio Arisaka,et al.  Silk Fibroin of Bombyx mori Is Secreted, Assembling a High Molecular Mass Elementary Unit Consisting of H-chain, L-chain, and P25, with a 6:6:1 Molar Ratio* , 2000, The Journal of Biological Chemistry.

[20]  Teruo Okano,et al.  Polymeric micelles as new drug carriers , 1996 .

[21]  Lorenz Meinel,et al.  Silk fibroin matrices for the controlled release of nerve growth factor (NGF). , 2007, Biomaterials.

[22]  Daniel S Kohane,et al.  Microparticles and nanoparticles for drug delivery. , 2007, Biotechnology and bioengineering.

[23]  O. Kratky,et al.  An Unstable Lattice in Silk Fibroin , 1950, Nature.

[24]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[25]  G. Freddi,et al.  Raman spectroscopic studies of silk fibroin fromBombyx mori , 1998 .

[26]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[27]  Lorenz Meinel,et al.  Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[28]  Wolfgang A. Weber,et al.  Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging , 2007, Proceedings of the National Academy of Sciences.

[29]  Gabriela A Silva,et al.  Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. , 2007, Advanced drug delivery reviews.

[30]  H. von Briesen,et al.  Targeted human serum albumin nanoparticles for specific uptake in EGFR-Expressing colon carcinoma cells. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[31]  V. Mottaghitalab,et al.  Fabrication of porous chitosan/poly(vinyl alcohol) reinforced single-walled carbon nanotube nanocomposites for neural tissue engineering. , 2011, Journal of biomedical nanotechnology.

[32]  S. Nie,et al.  Nanotechnology applications in cancer. , 2007, Annual review of biomedical engineering.

[33]  Z. Shao,et al.  Animal silks: their structures, properties and artificial production. , 2009, Chemical communications.

[34]  M. Sotomura,et al.  Entrapment of phenylalanine ammonia-lyase in silk fibroin for protection from proteolytic attack. , 1986, Biochemical and biophysical research communications.

[35]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[36]  Hans P Merkle,et al.  Formulation aspects of biodegradable polymeric microspheres for antigen delivery. , 2005, Advanced drug delivery reviews.

[37]  Ruth Duncan,et al.  Polymer conjugates as anticancer nanomedicines , 2006, Nature Reviews Cancer.

[38]  Brian J. Tighe,et al.  Polymers for biodegradable medical devices. 1. The potential of polyesters as controlled macromolecular release systems , 1986 .

[39]  M. Ziabari,et al.  Enhancement of neural cell lines proliferation using nano-structured chitosan/poly(vinyl alcohol) scaffolds conjugated with nerve growth factor , 2011 .

[40]  Robert Langer,et al.  Nanoparticle technologies for cancer therapy. , 2010, Handbook of experimental pharmacology.

[41]  M. Shokrgozar,et al.  Bio-hybrid silk fibroin/calcium phosphate/PLGA nanocomposite scaffold to control the delivery of vascular endothelial growth factor. , 2014, Materials science & engineering. C, Materials for biological applications.

[42]  Tabatabaei Qomi,et al.  The Design of Scaffolds for Use in Tissue Engineering , 2014 .

[43]  P. Hoet,et al.  Nanoparticles – known and unknown health risks , 2004, Journal of nanobiotechnology.

[44]  Jayanth Panyam,et al.  Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles. , 2003, International journal of pharmaceutics.

[45]  D. Kaplan,et al.  Production, structure and in vitro degradation of electrospun honeybee silk nanofibers. , 2011, Acta biomaterialia.

[46]  Y. Baimark,et al.  Preparation of Silk Fibroin Microspheres and Its Application to Protein Adsorption , 2009 .

[47]  A. R. Kulkarni,et al.  Biodegradable polymeric nanoparticles as drug delivery devices. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[48]  D. Kaplan,et al.  In vivo degradation of three-dimensional silk fibroin scaffolds. , 2008, Biomaterials.

[49]  Xungai Wang,et al.  Production of submicron silk particles by milling , 2013 .

[50]  Vladimir P Torchilin,et al.  Nanopreparations for organelle-specific delivery in cancer. , 2014, Advanced drug delivery reviews.

[51]  R. Arshady,et al.  Review : Biodegradable Microcapsular Drug Delivery Systems: Manufacturing Methodology, Release Control and Targeting Prospects , 1990 .

[52]  Krishnendu Roy,et al.  Biomaterials for stem cell differentiation. , 2008, Advanced drug delivery reviews.

[53]  D. Kaplan,et al.  Materials fabrication from Bombyx mori silk fibroin , 2011, Nature Protocols.

[54]  Y. Tabata,et al.  Self assembly of DNA nanoparticles with polycations for the delivery of genetic materials into cells. , 2006, Journal of nanoscience and nanotechnology.

[55]  Z. Chen.  Small-molecule delivery by nanoparticles for anticancer therapy. , 2010, Trends in molecular medicine.

[56]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[57]  A. Bangham,et al.  Membrane models with phospholipids. , 1968, Progress in biophysics and molecular biology.

[58]  Warren C W Chan,et al.  Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. , 2007, Nano letters.

[59]  Yasuhiko Tabata,et al.  Tissue regeneration based on growth factor release. , 2003, Tissue engineering.

[60]  L. Jia,et al.  Nanoparticles improve biological functions of phthalocyanine photosensitizers used for photodynamic therapy. , 2012, Current drug metabolism.

[61]  María J. Vicent,et al.  Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. , 2009, Advanced drug delivery reviews.

[62]  K. Leong,et al.  The design of scaffolds for use in tissue engineering. Part I. Traditional factors. , 2001, Tissue engineering.

[63]  Supachoke Mangmool,et al.  Pectin nanoparticle enhances cytotoxicity of methotrexate against hepG2 cells , 2013, Drug delivery.

[64]  Tejraj M Aminabhavi,et al.  Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[65]  H. Tavanai,et al.  Production of fibroin nanopowder through electrospraying , 2011 .

[66]  Yu Zhang,et al.  Biosynthesis of β-Glucosidase-Silk Fibroin Nanoparticles Conjugates and Enzymatic Characteristics , 2011 .

[67]  David L Kaplan,et al.  In vitro degradation of silk fibroin. , 2005, Biomaterials.

[68]  M. Schäfer-Korting,et al.  Solid lipid nanoparticles as drug carriers for topical glucocorticoids. , 2000, International journal of pharmaceutics.

[69]  K A Athanasiou,et al.  Basic science of articular cartilage repair. , 2001, Clinics in sports medicine.

[70]  Gordon L. Amidon,et al.  Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size , 1996, Pharmaceutical Research.

[71]  P. Phinyocheep,et al.  Preparation of porous silk fibroin microparticles by a water‐in‐oil emulsification‐diffusion method , 2010 .

[72]  Gordon L. Amidon,et al.  The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent , 1997, Pharmaceutical Research.

[73]  L. Meinel,et al.  Deciphering the mechanism of protein interaction with silk fibroin for drug delivery systems. , 2014, Biomaterials.

[74]  Christopher G Thanos,et al.  The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis. , 2006, Biomolecular engineering.

[75]  Yumin Yang,et al.  Degradation behaviors of nerve guidance conduits made up of silk fibroin in vitro and in vivo , 2009 .

[76]  Eric Doelker,et al.  Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[77]  J. Kreuter,et al.  Enhanced transport of nanoparticle associated drugs through natural and artificial membranes--a general phenomenon? , 1999, International journal of pharmaceutics.

[78]  D. Kaplan,et al.  pH‐Dependent Anticancer Drug Release from Silk Nanoparticles , 2013, Advanced healthcare materials.

[79]  P. Couvreur,et al.  Stealth® PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting , 1999 .

[80]  S. Rajput,et al.  Study on formulation variables of methotrexate loaded mesoporous MCM-41 nanoparticles for dissolution enhancement. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[81]  N. Wang,et al.  Poly(vinyl alcohol) nanoparticles prepared by freezing-thawing process for protein/peptide drug delivery. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[82]  Ung-Jin Kim,et al.  Structure and properties of silk hydrogels. , 2004, Biomacromolecules.

[83]  C. Cao,et al.  In vitro and in vivo degradation behavior of aqueous-derived electrospun silk fibroin scaffolds , 2010 .

[84]  J. Goh,et al.  Release and cellular acceptance of multiple drugs loaded silk fibroin particles. , 2011, International journal of pharmaceutics.

[85]  F. Sehnal,et al.  Identification of a Novel Type of Silk Protein and Regulation of Its Expression* , 1998, The Journal of Biological Chemistry.

[86]  K. Numata,et al.  Biocompatible and biodegradable dual-drug release system based on silk hydrogel containing silk nanoparticles. , 2012, Biomacromolecules.

[87]  Hao Wang,et al.  Effect of degumming time on silkworm silk fibre for biodegradable polymer composites , 2012 .

[88]  David L Kaplan,et al.  Silk-based biomaterials. , 2003, Biomaterials.

[89]  Jinrong Yao,et al.  The preparation of regenerated silk fibroin microspheres. , 2007, Soft matter.

[90]  A. Domb,et al.  Gene Transfer into the Lung by Nanoparticle Dextran-Spermine/Plasmid DNA Complexes , 2010, Journal of biomedicine & biotechnology.

[91]  D. Kaplan,et al.  Mechanisms of silk fibroin sol-gel transitions. , 2006, The journal of physical chemistry. B.

[92]  Shirui Mao,et al.  Recent advances in polymeric microspheres for parenteral drug delivery – part 1 , 2012, Expert opinion on drug delivery.

[93]  Shaker A Mousa,et al.  Nanoparticles and cancer therapy: A concise review with emphasis on dendrimers , 2009, International journal of nanomedicine.

[94]  Chun Xing Li.  Poly(L-glutamic acid)--anticancer drug conjugates. , 2002, Advanced drug delivery reviews.

[95]  K. Kisich,et al.  Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis. , 2007, International journal of pharmaceutics.

[96]  Ying Zhang,et al.  Advanced materials and processing for drug delivery: the past and the future. , 2013, Advanced drug delivery reviews.

[97]  Eleanor M. Pritchard,et al.  Antiepileptic effects of silk-polymer based adenosine release in kindled rats , 2009, Experimental Neurology.

[98]  J. P. Anderson.  Morphology and crystal structure of a recombinant silk-like molecule, SLP4 , 1998 .

[99]  Gerhard Winter,et al.  Recombinant spider silk particles for controlled delivery of protein drugs. , 2012, Biomaterials.

[100]  David L Kaplan,et al.  Sonication-induced gelation of silk fibroin for cell encapsulation. , 2008, Biomaterials.

[101]  Chao Zhang,et al.  Bovine serum albumin nanoparticles for delivery of tacrolimus to reduce its kidney uptake and functional nephrotoxicity. , 2015, International journal of pharmaceutics.

[102]  Yu-Qing Zhang,et al.  Highly efficient processing of silk fibroin nanoparticle-L-asparaginase bioconjugates and their characterization as a drug delivery system , 2011 .

[103]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[104]  R. Müller,et al.  Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. , 1996, Journal of drug targeting.

[105]  G. Vunjak‐Novakovic,et al.  Silk fibroin as an organic polymer for controlled drug delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[106]  D. Fischer,et al.  Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[107]  Hisatoshi Kobayashi,et al.  Design of Tissue-engineered Nanoscaffold Through Self-assembly of Peptide Amphiphile , 2006 .

[108]  A. Durand,et al.  Enzymatically degradable nanoparticles of dextran esters as potential drug delivery systems , 2012 .

[109]  Rassoul Dinarvand,et al.  Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study , 2012, International journal of nanomedicine.

[110]  Kyongbum Lee,et al.  Relationships between degradability of silk scaffolds and osteogenesis. , 2010, Biomaterials.

[111]  Martin Nicklas,et al.  Preparation and characterization of marine sponge collagen nanoparticles and employment for the transdermal delivery of 17β-estradiol-hemihydrate , 2009, Drug development and industrial pharmacy.

[112]  David L. Kaplan,et al.  Controlling silk fibroin particle features for drug delivery. , 2010, Biomaterials.

[113]  R L Reis,et al.  Journal of Tissue Engineering and Regenerative Medicine Silk Fibroin Microparticles as Carriers for Delivery of Human Recombinant Bmps. Physical Characterization and Drug Release , 2022 .

[114]  Steven P Schwendeman,et al.  BSA degradation under acidic conditions: a model for protein instability during release from PLGA delivery systems. , 2006, Journal of pharmaceutical sciences.

[115]  R. Arletti,et al.  Gelatin microspheres crosslinked with D,L-glyceraldehyde as a potential drug delivery system: preparation, characterisation, in vitro and in vivo studies. , 2001, International journal of pharmaceutics.

[116]  J. West,et al.  Vascularization of engineered tissues: approaches to promote angio-genesis in biomaterials. , 2008, Current topics in medicinal chemistry.

[117]  Robert Langer,et al.  Impact of nanotechnology on drug delivery. , 2009, ACS nano.

[118]  H. Dams-Kozlowska,et al.  Silk as an innovative biomaterial for cancer therapy. , 2015, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

[119]  E. Chiellini,et al.  Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications. , 2008, Nanomedicine.

[120]  Robert A Newman,et al.  Silk-fibroin-coated liposomes for long-term and targeted drug delivery , 2006, International journal of nanomedicine.

[121]  Gaurav Sharma,et al.  Current approaches to stabilising and analysing proteins during microencapsulation in PLGA , 2009 .

[122]  Ick Chan Kwon,et al.  Self-assembled hyaluronic acid nanoparticles for active tumor targeting. , 2010, Biomaterials.

[123]  M. Bawendi,et al.  Synthesis and characterization of nearly monodisperse CdE (E = sulfur, selenium, tellurium) semiconductor nanocrystallites , 1993 .

[124]  Samir Mitragotri,et al.  Synergistic Effect of Enhancers for Transdermal Drug Delivery , 2000, Pharmaceutical Research.

[125]  S. Kundu,et al.  Drug loading and release on tumor cells using silk fibroin–albumin nanoparticles as carriers , 2013, Nanotechnology.

[126]  Lorenz Meinel,et al.  Microporous silk fibroin scaffolds embedding PLGA microparticles for controlled growth factor delivery in tissue engineering. , 2009, Biomaterials.

[127]  David L. Kaplan,et al.  Hydrophobic Drug-Triggered Self-Assembly of Nanoparticles from Silk-Elastin-Like Protein Polymers for Drug Delivery , 2014, Biomacromolecules.

[128]  M. Rafiee-Tehrani,et al.  Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[129]  H. S. Azevedo,et al.  Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends , 2007, Journal of The Royal Society Interface.

[130]  M. Akashi,et al.  Preparation and characterization of biodegradable nanoparticles based on poly(gamma-glutamic acid) with l-phenylalanine as a protein carrier. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[131]  M. Alonso,et al.  Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. , 2001, International journal of pharmaceutics.

[132]  J Amédée,et al.  Cell-to-cell communication between osteogenic and endothelial lineages: implications for tissue engineering. , 2009, Trends in biotechnology.

[133]  Y. Shafieyan,et al.  Fabrication and characterization of poly(D,L-lactide-co-glycolide)/hydroxyapatite nanocomposite scaffolds for bone tissue regeneration. , 2010, Journal of biomedical materials research. Part A.

[134]  Jeroen Rouwkema,et al.  Endothelial cells assemble into a 3-dimensional prevascular network in a bone tissue engineering construct. , 2006, Tissue engineering.

[135]  L. Holle.  Pegaspargase: An Alternative? , 1997, The Annals of pharmacotherapy.

[136]  H. Hosseinkhani,et al.  Biodegradable polymer-metal complexes for gene and drug delivery. , 2009, Current drug safety.

[137]  S. Kundu,et al.  Molecular phylogeny of silk producing insects based on internal transcribed spacer DNA1. , 2006, Journal of biochemistry and molecular biology.

[138]  David L Kaplan,et al.  Silk fibroin microtubes for blood vessel engineering. , 2007, Biomaterials.

[139]  M. Khorramizadeh,et al.  Use of biotin targeted methotrexate–human serum albumin conjugated nanoparticles to enhance methotrexate antitumor efficacy , 2011, International journal of nanomedicine.

[140]  Y. S. Rao,et al.  Mucoadhesive microspheres for controlled drug delivery. , 2004, Biological & pharmaceutical bulletin.

[141]  M. Keating,et al.  L-asparaginase and PEG asparaginase--past, present, and future. , 1993, Leukemia & lymphoma.

[142]  C. Puglia,et al.  Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies. , 2005, Journal of pharmaceutical sciences.

[143]  A. Abdulamir,et al.  Engineered smart biomaterials for gene delivery , 2012 .

[144]  T. Hino,et al.  Change in secondary structure of silk fibroin during preparation of its microspheres by spray-drying and exposure to humid atmosphere. , 2003, Journal of colloid and interface science.

[145]  D. Kaplan,et al.  Silk-based delivery systems of bioactive molecules. , 2010, Advanced drug delivery reviews.

[146]  Ze Lu,et al.  Paclitaxel-Loaded Gelatin Nanoparticles for Intravesical Bladder Cancer Therapy , 2004, Clinical Cancer Research.

[147]  Hossein Hosseinkhani,et al.  3D in vitro technology for drug discovery. , 2012, Current drug safety.

[148]  C. Stremnitzer,et al.  Protamine nanoparticles with CpG-oligodeoxynucleotide prevent an allergen-induced Th2-response in BALB/c mice. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[149]  David L Kaplan,et al.  Nanolayer biomaterial coatings of silk fibroin for controlled release. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[150]  Young Ha Kim,et al.  Silk fibroin nanoparticles for cellular uptake and control release. , 2010, International journal of pharmaceutics.

[151]  Hossein Hosseinkhani,et al.  Self-assembled proteins and peptides for regenerative medicine. , 2013, Chemical reviews.

[152]  S. Tavangar,et al.  Structural and functional changes of silk fibroin scaffold due to hydrolytic degradation , 2014 .

[153]  Z. Shao,et al.  Paclitaxel-loaded silk fibroin nanospheres. , 2012, Journal of biomedical materials research. Part A.

[154]  Yulin Deng,et al.  Starch nanoparticle formation via reactive extrusion and related mechanism study , 2011 .

[155]  Jingwei Shao,et al.  Intracellular distribution and mechanisms of actions of photosensitizer Zinc(II)-phthalocyanine solubilized in Cremophor EL against human hepatocellular carcinoma HepG2 cells. , 2013, Cancer letters.

[156]  Amy Brock,et al.  Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment. , 2014, Advanced drug delivery reviews.

[157]  Mohsen Hosseinkhani,et al.  In Vitro Sustained Release and Degradation Study of Biodegradable Poly(D, L-lactic acid) Microspheres Loading Theophylline , 2009 .

[158]  Mingshui Chen,et al.  PLGA-nanoparticle mediated delivery of anti-OX40 monoclonal antibody enhances anti-tumor cytotoxic T cell responses. , 2014, Cellular immunology.

[159]  K. Matyjaszewski,et al.  Synthesis and Biodegradation of Nanogels as Delivery Carriers for Carbohydrate Drugs , 2007 .

[160]  Cato T Laurencin,et al.  Polymers as biomaterials for tissue engineering and controlled drug delivery. , 2006, Advances in biochemical engineering/biotechnology.

[161]  K. Matsumoto,et al.  Enhanced suppression of tumor growth using a combination of NK4 plasmid DNA-PEG engrafted cationized dextran complex and ultrasound irradiation , 2005, Cancer Gene Therapy.

[162]  J. Benoit,et al.  How to achieve sustained and complete protein release from PLGA-based microparticles? , 2008, International journal of pharmaceutics.

[163]  Chenhua Zhao,et al.  Structural characterization and artificial fiber formation of Bombyx mori silk fibroin in hexafluoro‐iso‐propanol solvent system , 2003, Biopolymers.

[164]  C. Walsh.  Molecular mechanisms that confer antibacterial drug resistance , 2000, Nature.

[165]  C. Peng,et al.  Calcium‐Alginate Nanoparticles Formed by Reverse Microemulsion as Gene Carriers , 2005 .

[166]  Mansoor M. Amiji,et al.  BIODEGRADABLE POLY (E-CAPROLACTONE) NANOPARTICLES FOR TUMOR-TARGETED DELIVERY OF TAMOXIFEN , 2002 .

[167]  David L Kaplan,et al.  Mapping domain structures in silks from insects and spiders related to protein assembly. , 2004, Journal of molecular biology.

[168]  Michel Boissière,et al.  潜在的な発光および磁気2モード画像化プローブとしてのポリオール合成Zn0.9Mn0.1ナノ粒子:合成,特性評価,および毒性研究 , 2012 .

[169]  Xungai Wang,et al.  Silk powder for regenerative medicine , 2014 .

[170]  H. Fessi,et al.  Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies. , 2005, Critical reviews in therapeutic drug carrier systems.

[171]  E. Locatelli,et al.  Biodegradable PLGA-b-PEG polymeric nanoparticles: synthesis, properties, and nanomedical applications as drug delivery system , 2012, Journal of Nanoparticle Research.

[172]  R. Müller,et al.  Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[173]  Y. Shafieyan,et al.  Porous crosslinked poly(ε-caprolactone fumarate)/nanohydroxyapatite composites for bone tissue engineering. , 2012, Journal of biomedical materials research. Part A.

[174]  Yu-Qing Zhang,et al.  Biosynthesis of insulin-silk fibroin nanoparticles conjugates and in vitro evaluation of a drug delivery system , 2009 .

[175]  Young Hwan Park,et al.  Morphology of regenerated silk fibroin: Effects of freezing temperature, alcohol addition, and molecular weight , 2001 .

[176]  Xu Wang,et al.  Application of Nanotechnology in Cancer Therapy and Imaging , 2008, CA: a cancer journal for clinicians.

[177]  S. Kundu,et al.  Folate conjugated silk fibroin nanocarriers for targeted drug delivery. , 2014, Integrative biology : quantitative biosciences from nano to macro.

[178]  Ahmed O Elzoghby,et al.  Protein-based nanocarriers as promising drug and gene delivery systems. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[179]  V. Shah,et al.  Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance. , 1994, Journal of pharmaceutical sciences.

[180]  M. S. Muthu,et al.  PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[181]  Lorenz Meinel,et al.  Silk fibroin spheres as a platform for controlled drug delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[182]  Rajesh Singh,et al.  Nanoparticle-based targeted drug delivery. , 2009, Experimental and molecular pathology.

[183]  J. Lehár,et al.  Synergistic drug combinations improve therapeutic selectivity , 2009, Nature Biotechnology.

[184]  S. Kim,et al.  Simple preparation and characteristics of silk fibroin microsphere , 2003 .

[185]  Changsheng Liu,et al.  Preparation and characterization of bioactive mesoporous wollastonite - Polycaprolactone composite scaffold. , 2009, Biomaterials.

[186]  Y. Tabata,et al.  Ultrasound enhances the transfection of plasmid DNA by non-viral vectors. , 2003, Current pharmaceutical biotechnology.

[187]  D. Kaplan,et al.  Biomaterials from ultrasonication-induced silk fibroin-hyaluronic acid hydrogels. , 2010, Biomacromolecules.

[188]  Clive G. Wilson,et al.  Polybutylcyanoacrylate nanoparticles for the delivery of [75Se]norcholestenol , 1983 .

[189]  K. Numata.  Silk hydrogels for tissue engineering and dual-drug delivery , 2014 .

[190]  P. Garside,et al.  Crystallinity and degradation of silk: correlations between analytical signatures and physical condition on ageing , 2007 .

[191]  F. Mottaghitalab,et al.  Aptamer decorated hyaluronan/chitosan nanoparticles for targeted delivery of 5-fluorouracil to MUC1 overexpressing adenocarcinomas. , 2015, Carbohydrate polymers.

[192]  J. Irache,et al.  Casein nanoparticles as carriers for the oral delivery of folic acid , 2015 .

[193]  David L Kaplan,et al.  Antibiotic‐Releasing Silk Biomaterials for Infection Prevention and Treatment , 2013, Advanced functional materials.

[194]  Hans Laufer,et al.  Polypeptides of fibroin and sericin secreted from the different sections of the silk gland in Bombyx mori , 1977 .

[195]  J. Goh,et al.  Self-assembled silk fibroin particles: Tunable size and appearance , 2012 .

[196]  A. Mathur,et al.  Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Fabrication and Characterization of Silk Fibroin-derived Curcumin Nanoparticles for Cancer Therapy , 2022 .

[197]  C. M. Owens,et al.  Chemical combinations elucidate pathway interactions and regulation relevant to Hepatitis C replication , 2010 .

[198]  C James Kirkpatrick,et al.  Tissue-like self-assembly in cocultures of endothelial cells and osteoblasts and the formation of microcapillary-like structures on three-dimensional porous biomaterials. , 2007, Biomaterials.

[199]  L. Meinel,et al.  Silk fibroin as a vehicle for drug delivery applications. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[200]  L. Brannon-Peppas,et al.  Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.

[201]  M. El-Sayed,et al.  Chemistry and properties of nanocrystals of different shapes. , 2005, Chemical reviews.

[202]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[203]  Y. Tabata,et al.  In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[204]  K. Hirabayashi,et al.  Effect of preparation method of powdered silk on the mechanical properties of moulded silk , 1994 .

[205]  Raul Machado,et al.  Thermoresponsive self-assembled elastin-based nanoparticles for delivery of BMPs. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[206]  David L Kaplan,et al.  Silk-based biomaterials for sustained drug delivery. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[207]  J. Homsi,et al.  Phase I Trial of Poly-l-Glutamate Camptothecin (CT-2106) Administered Weekly in Patients with Advanced Solid Malignancies , 2007, Clinical Cancer Research.

[208]  A. Lowman,et al.  Biodegradable nanoparticles for drug delivery and targeting , 2002 .

[209]  Xungai Wang,et al.  Ultra-fine silk powder preparation through rotary and ball milling , 2008 .

[210]  J. Gosline,et al.  The mechanical design of spider silks: from fibroin sequence to mechanical function. , 1999, The Journal of experimental biology.

[211]  L. Grasset,et al.  Woven silk as a carrier for the immobilization of enzymes. , 1977, Biotechnology and bioengineering.

[212]  R. Naik,et al.  Thermally Induced α-Helix to β-Sheet Transition in Regenerated Silk Fibers and Films , 2005 .

[213]  Thomas Scheibel,et al.  Composite materials based on silk proteins , 2010 .

[214]  Hua Guo,et al.  pH-sensitive pullulan-based nanoparticle carrier for adriamycin to overcome drug-resistance of cancer cells. , 2014, Carbohydrate polymers.

[215]  J. Irache,et al.  Development of Drug Delivery Systems from Vegetal Proteins: Legumin Nanoparticles , 1996 .

[216]  Mingzhong Li,et al.  Enzymatic degradation behavior of porous silk fibroin sheets. , 2003, Biomaterials.

[217]  David J Mooney,et al.  VEGF Scaffolds Enhance Angiogenesis and Bone Regeneration in Irradiated Osseous Defects , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[218]  C. Migliaresi,et al.  Regenerated silk fibroin films: Thermal and dynamic mechanical analysis , 2002 .

[219]  Rangam Rajkhowa,et al.  Silk fibroin biomaterials for tissue regenerations. , 2013, Advanced drug delivery reviews.

[220]  Lianyan Wang,et al.  Preparation and improvement of release behavior of chitosan microspheres containing insulin. , 2006, International journal of pharmaceutics.

[221]  I. Ezpeleta,et al.  Gliadin nanoparticles for the controlled release of all-trans-retinoic acid , 1996 .

[222]  L. Zhuge,et al.  Formation of silk fibroin nanoparticles in water-miscible organic solvent and their characterization , 2007 .

[223]  F. Balis,et al.  Pharmacokinetics of PEG-l-asparaginase and plasma and cerebrospinal fluidl-asparagine concentrations in the rhesus monkey , 2004, Cancer Chemotherapy and Pharmacology.

[224]  K. Subramani,et al.  Targeting Nanoparticles as Drug Delivery Systems for Cancer Treatment , 2009 .

[225]  James R. Dewald,et al.  A New Class of Polymers: Starburst-Dendritic Macromolecules , 1985 .

[226]  A. Mathur,et al.  Silk fibroin-derived nanoparticles for biomedical applications. , 2010, Nanomedicine.

[227]  Si-Shen Feng,et al.  Nanoparticles of biodegradable polymers for new-concept chemotherapy , 2004, Expert review of medical devices.

[228]  Vincent M. Rotello,et al.  Fabrication and Self-Optimization of Multivalent Receptors on Nanoparticle Scaffolds , 2000 .

[229]  F. Kiessling,et al.  Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[230]  David L. Kaplan,et al.  Protein-Based Materials , 1997, Bioengineering of Materials.

[231]  Evangelia Bellas,et al.  Functionalized Silk Biomaterials for Wound Healing , 2013, Advanced healthcare materials.

[232]  A. Ghaemi,et al.  Chitosan nanoparticles as a potential nonviral gene delivery for HPV-16 E7 into mammalian cells , 2015, Artificial cells, nanomedicine, and biotechnology.

[233]  David L Kaplan,et al.  Silk nanospheres and microspheres from silk/pva blend films for drug delivery. , 2010, Biomaterials.

[234]  T. Yamane,et al.  A repeated beta-turn structure in poly(Ala-Gly) as a model for silk I of Bombyx mori silk fibroin studied with two-dimensional spin-diffusion NMR under off magic angle spinning and rotational echo double resonance. , 2001, Journal of molecular biology.

[235]  Zhang Yu.  Preparation of Silk Fibroin Nanoparticles and Their Application to Immobilization of L-Asparaginase , 2008 .

[236]  Karthikeyan Subramani,et al.  Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. , 2011, Chemical reviews.

[237]  Robert Langer,et al.  Nanotechnology in drug delivery and tissue engineering: from discovery to applications. , 2010, Nano letters.

[238]  David L Kaplan,et al.  Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo. , 2006, Journal of biomedical materials research. Part A.

[239]  Guangjun Nie,et al.  Nanotechnological strategies for therapeutic targeting of tumor vasculature. , 2013, Nanomedicine.

[240]  M. Shokrgozar,et al.  Sustained release of platelet-derived growth factor and vascular endothelial growth factor from silk/calcium phosphate/PLGA based nanocomposite scaffold. , 2013, International journal of pharmaceutics.

[241]  Jingwei Shao,et al.  Nanotechnology-based intelligent drug design for cancer metastasis treatment. , 2014, Biotechnology advances.

[242]  P. Korrapati,et al.  Electrospun zein/eudragit nanofibers based dual drug delivery system for the simultaneous delivery of aceclofenac and pantoprazole. , 2012, International journal of pharmaceutics.

[243]  R. Duncan.  The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.